Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17,255,853
-
Total 13F shares
-
9,521,654
-
Share change
-
-1,310,793
-
Total reported value
-
$29,799,342
-
Put/Call ratio
-
0%
-
Price per share
-
$3.13
-
Number of holders
-
69
-
Value change
-
-$4,112,095
-
Number of buys
-
21
-
Number of sells
-
43
Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q3 2024
As of 30 Sep 2024,
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,521,654 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Solas Capital Management, LLC, VANGUARD GROUP INC, Alta Fundamental Advisers LLC, Prosight Management, LP, Newtyn Management, LLC, ACADIAN ASSET MANAGEMENT LLC, RBF Capital, LLC, BlackRock, Inc., and Verition Fund Management LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.